Abstract

This article explores how AI may improve clinical research through its ability to better translate RWD into real-world evidence (RWE), thus providing more valid evidence of clinical benefits and risks. Dan Riskin, MD, of Verantos, Rich Glinklich, MD of OM1, and Sebastian Schneeweiss, MD of Aetion all shared their valuable insights into how AI is transforming clinical research.